Dental AI company Pearl was granted FDA 510(k) clearance for the detection of dental pathologies on panoramic X-rays.
Pearl’s Second Opinion platform is now available to use to identify caries, periapical radiolucencies and impacted third molars on panoramic radiographs, according to a Dec. 18 news release.
The company said the clearance was supported by a standalone performance study and a fully crossed multi-reader, multi-case study.
At the Becker's 5th Annual Future of Dentistry Roundtable, taking place September 14-15 in Chicago, dental leaders and executives will gain insights into emerging technologies, practice growth strategies and the evolving landscape of dental care delivery, with a focus on innovation, patient experience and operational excellence. Apply for complimentary registration now.
